circTADA2A Retards the Progression of Colorectal Cancer via Regulating miR-1229/BCL2L10 Signal Axis

References

• BrayF, FerlayJ, SoerjomataramI, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• BrennerH, KloorM, PoxCP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502. doi:10.1016/S0140-6736(13)61649-924225001
   PubMed Web of Science ®Google Scholar
• YangL, ParkinDM, LiLD, et al. Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer. 2004;90(11):2157–2166. doi:10.1038/sj.bjc.660181315150609
   PubMed Web of Science ®Google Scholar
• DienstmannR, VermeulenL, GuinneyJ, et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer. 2017;17(4):268. doi:10.1038/nrc.2017.24
   PubMed Web of Science ®Google Scholar
• SmithRA, von EschenbachAC, WenderR, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001–testing for early lung cancer detection. CA Cancer J Clin. 2001;51(1):38–75. doi:10.3322/canjclin.51.1.3811577479
   PubMed Web of Science ®Google Scholar
• YazganO, KrebsJE. Noncoding but nonexpendable: transcriptional regulation by large noncoding RNA in eukaryotes. Biochem Cell Biol. 2007;85(4):484–496. doi:10.1139/O07-06117713583
   PubMed Web of Science ®Google Scholar
• MatsuiM, CoreyDR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–179. doi:10.1038/nrd.2016.11727444227
   PubMed Web of Science ®Google Scholar
• TaftRJ, PangKC, MercerTR, et al. Non-coding RNAs: regulators of disease. J Pathol. 2010;220(2):126–139. doi:10.1002/path.263819882673
   PubMed Web of Science ®Google Scholar
• KristensenLS, AndersenMS, StagstedLVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-731395983
   PubMed Web of Science ®Google Scholar
• ConnSJ, PillmanK, ToubiaJ, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134. doi:10.1016/j.cell.2015.02.01425768908
   PubMed Web of Science ®Google Scholar
• GuoJU, AgarwalV, GuoH, et al. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409. doi:10.1186/s13059-014-0409-z25070500
   PubMed Web of Science ®Google Scholar
• KristensenLS, HansenTB, VenøMT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• MengS, ZhouH, FengZ, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. doi:10.1186/s12943-017-0663-228535767
   PubMed Web of Science ®Google Scholar
• JuH, ZhaoQ, WangF, et al. A circRNA signature predicts postoperative recurrence in stage II/III colon cancer. EMBO Mol Med. 2019;11(10):e10168. doi:10.15252/emmm.20181016831475771
   PubMed Web of Science ®Google Scholar
• BarrettSP, SalzmanJ. Circular RNAs: analysis, expression and potential functions. Development. 2016;143(11):1838–1847. doi:10.1242/dev.12807427246710
   PubMed Web of Science ®Google Scholar
• LiZ, HuangC, BaoC, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–264. doi:10.1038/nsmb.295925664725
   PubMed Web of Science ®Google Scholar
• Ashwal-FlussR, MeyerM, PamudurtiNR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi:10.1016/j.molcel.2014.08.01925242144
   PubMed Web of Science ®Google Scholar
• YangQ, DuWW, WuN, et al. A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation. Cell Death Differ. 2017;24(9):1609–1620. doi:10.1038/cdd.2017.8628622299
   PubMed Web of Science ®Google Scholar
• JemalA, BrayF, CenterMM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• JinY, YuLL, ZhangB, et al. Circular RNA hsa_circ_0000523 regulates the proliferation and apoptosis of colorectal cancer cells as miRNA sponge. Braz J Med Biol Res. 2018;51(12):e7811. doi:10.1590/1414-431x2018781130403259
   PubMed Web of Science ®Google Scholar
• MillerKD, SiegelRL, LinCC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. doi:10.3322/caac.2134927253694
   PubMed Web of Science ®Google Scholar
• Cantero-MuñozP, UriénMA, Ruano-RavinaA. Efficacy and safety of intraoperative radiotherapy in colorectal cancer: a systematic review. Cancer Lett. 2011;306(2):121–133. doi:10.1016/j.canlet.2011.02.02021414718
   PubMed Web of Science ®Google Scholar
• XuH, WangC, SongH, et al. RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019;18(1):8. doi:10.1186/s12943-018-0932-830630466
   PubMed Web of Science ®Google Scholar
• ChenS, ZhangL, SuY, et al. Screening potential biomarkers for colorectal cancer based on circular RNA chips. Oncol Rep. 2018;39(6):2499–2512.29658599
   PubMed Web of Science ®Google Scholar
• ZengK, ChenX, XuM, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018;9(4):417. doi:10.1038/s41419-018-0454-829549306
   PubMed Web of Science ®Google Scholar
• WangX, ZhangH, YangH, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14(3):539–555. doi:10.1002/1878-0261.1262931901148
   PubMed Web of Science ®Google Scholar
• LiYF, PeiFL, CaoMZ. CircRNA_101951 promotes migration and invasion of colorectal cancer cells by regulating the KIF3A-mediated EMT pathway. Exp Ther Med. 2020;19(5):3355–3361.32266033
   PubMed Web of Science ®Google Scholar
• WuY, XieZ, ChenJ, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019;18(1):73. doi:10.1186/s12943-019-1007-130940151
   PubMed Web of Science ®Google Scholar
• XuJZ, ShaoCC, WangXJ, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019;10(3):175. doi:10.1038/s41419-019-1382-y30787278
   PubMed Web of Science ®Google Scholar
• LiZ, YaoH, WangS, et al. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis. J Exp Clin Cancer Res. 2020;39(1):1–14.31928527
   PubMed Web of Science ®Google Scholar
• SalmenaL, L.P, Y.T, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.01421802130
   PubMed Web of Science ®Google Scholar
• ThomsonDW, DingerME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283. doi:10.1038/nrg.2016.2027040487
   PubMed Web of Science ®Google Scholar
• PolisenoL, SalmenaL, ZhangJ, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465(7301):1033–1038. doi:10.1038/nature0914420577206
   PubMed Web of Science ®Google Scholar
• SongW, FuT. Circular RNA-associated competing endogenous RNA network and prognostic nomogram for patients with colorectal cancer. Front Oncol. 2019;9:1181. doi:10.3389/fonc.2019.0118131781492
   PubMed Web of Science ®Google Scholar
• HuHY, YuCH, ZhangHH, et al. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2. Int J Biol Macromol. 2019;132:470–477. doi:10.1016/j.ijbiomac.2019.03.22130936013
   PubMed Web of Science ®Google Scholar
• LeeSY, KwonJ, WooJH, et al. Bcl2l10 mediates the proliferation, invasion and migration of ovarian cancer cells. Int J Oncol. 2020;56(2):618–629.31894274
   PubMed Web of Science ®Google Scholar
• XuJ, CaoX, LongZ, et al. BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells. J Pathol. 2011;223(3):400–409. doi:10.1002/path.281121171085
   PubMed Web of Science ®Google Scholar
• BaiY, WangJ, HanJ, et al. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo. Mol Carcinog. 2017;56(3):1137–1149. doi:10.1002/mc.2258027770580
   PubMed Web of Science ®Google Scholar